Title: Sublingual Immunotherapy for Allergic Rhinoconjunctivitis, Allergic Asthma, and Prevention of Allergic Diseases
Abstract: Sublingual immunotherapy (SLIT) is an efficacious and safe alternative to subcutaneous immunotherapy (SCIT). During the last three decades, SLIT has been widely used in many countries, primarily in central and southern Europe, where more than 50% of the current population of patients receiving specific immunotherapy are on SLIT (1).
Publication Year: 2008
Publication Date: 2008-08-19
Language: en
Type: article
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 18
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot